Schambye Hans T. - 03 Jan 2025 Form 4 Insider Report for Galecto, Inc. (GLTO)

Role
Chief Executive Officer, Director
Signature
/s/ Lori Firmani, attorney-in-fact
Issuer symbol
GLTO
Transactions as of
03 Jan 2025
Net transactions value
-$7,510
Form type
4
Filing time
07 Jan 2025, 16:00:03 UTC
Previous filing
11 Oct 2024
Next filing
08 Jul 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GLTO Common Stock Options Exercise +2,640 +126% 4,738 03 Jan 2025 Direct F1
transaction GLTO Common Stock Sale $7,510 -1,341 -28% $5.60 3,397 03 Jan 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GLTO Restricted Stock Units Options Exercise $0 -2,640 -33% $0.000000 5,360 03 Jan 2025 Common Stock 2,640 Direct F1, F3
transaction GLTO Stock Option (right to buy) Award $0 +16,400 $0.000000 16,400 03 Jan 2025 Common Stock 16,400 $5.70 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents the right to receive, at settlement, one share of common stock of the Issuer. This transaction represents the settlement of RSUs in shares of common stock on their scheduled vesting date.
F2 Shares sold to cover tax obligations in connection with the vesting of the RSUs listed in Table II. This sale is mandated by the Issuer's election under its 2020 Equity Incentive Plan and does not represent a discretionary trade by the Reporting Person.
F3 This award was granted on January 3, 2024. One-third of the RSUs subject to the award vested on January 3, 2025 and one-sixth of the RSUs subject to the award award will vest ratably every six months thereafter, assuming continued employment through the applicable vesting date.
F4 25% of the shares subject to such option will vest and become exercisable on January 3, 2026 and the remainder of the shares vest in substantially equal monthly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.